Over the latest trailing 12-month period, price cagr is -51.02%. The comparable SPY value is +16.49%. Year-to-date price return is -13.49%. Price CAGR uses adjusted close price history and excludes dividends.
Over longer horizons, Price CAGR averages 49.88% over 3 years and 26.70% over 5 years; the trailing 12 months came in at -51.02%. The price CAGR (Compound Annual Growth Rate) shows how the company's stock price has grown over various time periods. This measures pure price appreciation without including dividends.
Hims & Hers Health, Inc. (HIMS)
Price growth vs the same quarter one year earlier, last 25 quarters.
Quarter-end adjusted closing prices; the newest quarter may be quarter-to-date.
| Year | Start Price | End Price | Change | % Change |
|---|---|---|---|---|
| 2026 (YTD) | $32.47 | $28.09 | −$4.38 | -13.49% |
| 2025 | $24.18 | $32.47 | +$8.29 | +34.28% |
| 2024 | $8.9 | $24.18 | +$15.28 | +171.69% |
| 2023 | $6.41 | $8.9 | +$2.49 | +38.85% |
| 2022 | $6.55 | $6.41 | −$0.14 | -2.14% |
| 2021 | $14.6 | $6.55 | −$8.05 | -55.14% |
| 2020 | $9.9 | $14.6 | +$4.7 | +47.47% |
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q3 2026 (QTD) | $28.09 | -19.0% | -52.5% |
| Q2 2026 | $34.67 | +67.0% | -29.8% |
| Q1 2026 | $20.76 | -37.2% | -28.8% |
| Q4 2025 | $33.05 | -44.1% | +31.3% |
| Q3 2025 | $59.12 | +19.7% | +232.7% |
| Q2 2025 | $49.41 | +69.6% | +146.8% |
| Q1 2025 | $29.14 | +15.8% | +88.4% |
| Q4 2024 | $25.17 | +41.6% | +178.7% |
| Q3 2024 | $17.77 | -11.2% | +182.5% |
| Q2 2024 | $20.02 | +29.4% | +120.2% |
| Q1 2024 | $15.47 | +71.3% | +56.1% |
| Q4 2023 | $9.03 | +43.6% | +41.5% |
| Q3 2023 | $6.29 | -30.8% | +12.7% |
| Q2 2023 | $9.09 | -8.3% | +100.7% |
| Q1 2023 | $9.91 | +55.3% | +85.9% |
| Q4 2022 | $6.38 | +14.3% | -2.6% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier. The newest quarter is in progress (quarter-to-date).
